معرفی
Dr. Damien McHugh serves as an Honorary Research Associate in the Division of Cancer Sciences at the University of Manchester, specializing in advanced magnetic resonance imaging (MRI) applications for oncology. His work bridges quantitative imaging biomarker development with clinical radiotherapy, particularly using MR-Linac systems to monitor treatment response across multiple cancer types.
His academic credentials include:
- Doctor of Philosophy (PhD) in The effect of tumour microstructure on diffusion-weighted MRI measurements, University of Manchester (2015)
- Master of Physics (MPhys), University of Manchester (2010)
McHugh's research centers on diffusion MRI and tumour microstructure analysis, with significant contributions to hypoxia imaging, biomarker validation, and geometric distortion correction in radiation therapy settings. His fingerprint reveals expertise in Magnetic Resonance Imaging (100%), Tumor Microstructure (65%), and Diffusion-Weighted MRI (51%), emphasizing translational applications for bladder, prostate, head/neck, and oropharyngeal cancers.
Recent publications (2024-2025) demonstrate a cohesive trajectory in optimizing MRI for real-time radiotherapy adaptation, including BOLD MRI for oxygenation mapping, ADC-based dose-response modeling, and robust diffusion-weighted protocols for MR-Linac systems. These works consistently address clinical challenges like target volume delineation and heterogeneity assessment.
His scientific recognition includes:
- 2nd Place for Best Abstract Presentation in the Quantitative MR Study Group at ISMRM 2017
As an active member of the Manchester Cancer Research Centre, McHugh collaborates within multidisciplinary teams integrating physics, oncology, and radiology to advance imaging-driven cancer treatment protocols.
